Crinetics Pharmaceuticals Inc buy Morgan Stanley
Start price
06.01.26
/
50%
€39.40
Target price
06.01.27
€68.23
Performance (%)
-14.57%
Price
10.04.26
€33.66
Summary
This prediction is currently active. The price of Crinetics Pharmaceuticals Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.57%. This prediction currently runs until 06.01.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Crinetics Pharmaceuticals Inc | 6.519% | 6.519% |
| iShares Core DAX® | 2.554% | 0.562% |
| iShares Nasdaq 100 | 2.742% | -0.599% |
| iShares Nikkei 225® | 6.584% | 4.336% |
| iShares S&P 500 | 1.930% | -0.507% |
Comments by Morgan_Stanley for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals (NASDAQ:CRNX) had its price target raised by analysts at Morgan Stanley from $77.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€37.40
29.09.25
29.09.25
€65.69
29.09.26
29.09.26
-10.00%
10.04.26
10.04.26
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€44.80
23.05.24
23.05.24
€64.64
23.05.25
23.05.25
-42.86%
24.05.25
24.05.25